UK markets closed

Defence Therapeutics Inc. (DTCFF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.87650.0000 (0.00%)
As of 02:24PM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2022
30/06/2021
30/06/2020
Total revenue
0
0
0
0
Operating expenses
Research development
4,325
3,760
1,159
433.451
Selling general and administrative
2,643
3,560
1,701
239.731
Total operating expenses
6,990
7,320
2,859
673.182
Operating income or loss
-6,990
-7,320
-2,859
-673.182
Total other income/expenses net
-69.34
-23.867
-
-
Income before tax
-7,212
-7,344
-2,859
-673.182
Income from continuing operations
-7,212
-7,344
-2,859
-673.182
Net income
-7,212
-7,344
-2,859
-673.182
Net income available to common shareholders
-7,212
-7,344
-2,859
-673.182
Basic EPS
-0.19
-0.20
-0.11
-0.02
Diluted EPS
-0.19
-0.20
-0.11
-0.02
Basic average shares
37,989
36,077
26,596
34,799
Diluted average shares
37,989
36,077
26,596
34,799